Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate Ruchika Sharma30 Jan 2025 2:30 PM ISTHyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned foreign...
USFDA nod to Granules India arm for ADHD treatment Ruchika Sharma17 Dec 2024 1:30 PM ISTHyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Torrent Group market capitalisation doubles to USD 20 billion in a year Ruchika Sharma9 Jun 2024 6:30 PM ISTThe Torrent Group, a diversified conglomerate, surpassed $20 billion (Rs 1.68 lakh crore) in market capitalization on Friday. This represents nearly a...
Lupin bags USFDA nod for hyperuricemia treatment drug Febuxostat Ruchika Sharma19 Jan 2024 1:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
6 medicines of Alembic Pharma received USFDA nod during Q2FY24 Ruchika Sharma4 Oct 2023 12:30 PM ISTMumbai: Alembic Pharmaceuticals Limited has announced that it has received US Food & Drug Administration (USFDA) approvals on six of its...
CDSCO raises alert on fake Adcetris injection manufactured by Takeda Pharma Roshni Dhar9 Sept 2023 12:32 PM ISTConcerning falsified versions of Adcetris Injection (Brentuximab Vedotin) manufactured by Takeda Pharmaceutical, the Central Drugs Standard Control...
Aurobindo Pharma arm secures USFDA okay for Icatibant Injection Ruchika Sharma16 Aug 2023 2:30 PM ISTIcatibant Injection is indicated for treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Takeda, HUTCHMED gets EMA validation for marketing authorization application for Fruquintinib for Metastatic Colorectal Cancer Ruchika Sharma18 Jun 2023 12:15 PM ISTOsaka: Takeda and HUTCHMED (China) Limited have announced that the European Medicines Agency (EMA) has validated and accepted for regulatory...
Japan's Takeda Pharma profit slips 13 percent, pipeline bolsters outlook Ruchika Sharma5 Feb 2023 10:00 AM ISTThe company said core operating profit, which strips out non-recurring items, increased 26 percent in the nine-month period.
Granules Pharma bags USFDA nod for ADHD drug Amphetamine Mixed Salts ER Ruchika Sharma24 Jan 2023 12:02 PM ISTMixed Salts of a Single-Entity Amphetamine ER Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Takeda Pharma's India operations become United Nations Global Compact signatory Ruchika Sharma27 Sept 2022 1:15 PM ISTNew Delhi: Takeda Pharmaceutical Company Limited has announced that its India operations have become a signatory of the United Nations Global Compact...
